Sara N Davison1, Gian S Jhangri2, Jonathan Koffman3. 1. Division of Nephrology & Immunology, University of Alberta, Edmonton, Alberta, Canada. 2. School of Public Health, University of Alberta, Edmonton, Alberta, Canada. 3. Cicely Saunders Institute, Department of Palliative Care, Policy and Rehabilitation, King's College London School of Medicine, London, UK.
Abstract
OBJECTIVES: Palliative care is greatly underutilised for patients dying from advanced chronic kidney disease (CKD). This study explored CKD patients' knowledge of, and attitudes to, palliative and hospice care. DESIGN AND INTERVENTION: This was a cross-sectional interview-based survey of stage 5 CKD patients. SETTING: Both dialysis patients and those managed without dialysis were assessed in a university-based renal programme in Alberta, Canada. OUTCOME MEASURES: The primary outcome was validated patient knowledge of, and attitudes, towards palliative and hospice care. Secondary analyses of associations between knowledge and potential explanatory variables such as patient demographics, living circumstances, self-assigned ethnicity, socioeconomic position and sources of knowledge were explored. RESULTS: Only 22.2% and 17.9% of 436 patients surveyed possessed a correct understanding of palliative and hospice care, respectively, and perceptions were mostly negative. Sources of knowledge of these services rarely involved healthcare professionals (3.1%-7.7%). Multivariable analysis identified that white participants were more than 12 times more likely to have accurate knowledge than non-Caucasian patients, not accounted for by socioeconomic position. Accurate knowledge was also more likely among patients who had personal experience with palliative care, or obtained their knowledge firsthand from family and friends. After palliative and hospice care were described, the vast majority of patients felt these services were valuable and should be offered to patients with advanced CKD (87.8% and 89.7%, respectively). CONCLUSIONS: Based on study findings, CKD patient and family education about the benefits of palliative and hospice services is likely important in optimal use of these services. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
OBJECTIVES: Palliative care is greatly underutilised for patients dying from advanced chronic kidney disease (CKD). This study explored CKD patients' knowledge of, and attitudes to, palliative and hospice care. DESIGN AND INTERVENTION: This was a cross-sectional interview-based survey of stage 5 CKD patients. SETTING: Both dialysis patients and those managed without dialysis were assessed in a university-based renal programme in Alberta, Canada. OUTCOME MEASURES: The primary outcome was validated patient knowledge of, and attitudes, towards palliative and hospice care. Secondary analyses of associations between knowledge and potential explanatory variables such as patient demographics, living circumstances, self-assigned ethnicity, socioeconomic position and sources of knowledge were explored. RESULTS: Only 22.2% and 17.9% of 436 patients surveyed possessed a correct understanding of palliative and hospice care, respectively, and perceptions were mostly negative. Sources of knowledge of these services rarely involved healthcare professionals (3.1%-7.7%). Multivariable analysis identified that white participants were more than 12 times more likely to have accurate knowledge than non-Caucasian patients, not accounted for by socioeconomic position. Accurate knowledge was also more likely among patients who had personal experience with palliative care, or obtained their knowledge firsthand from family and friends. After palliative and hospice care were described, the vast majority of patients felt these services were valuable and should be offered to patients with advanced CKD (87.8% and 89.7%, respectively). CONCLUSIONS: Based on study findings, CKD patient and family education about the benefits of palliative and hospice services is likely important in optimal use of these services. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Authors: Nneka N Ufere; John Donlan; Lauren Waldman; Arpan Patel; Jules L Dienstag; Lawrence S Friedman; Kathleen E Corey; Nikroo Hashemi; Peter Carolan; Alan C Mullen; Michael Thiim; Irun Bhan; Ryan Nipp; Joseph Greer; Jennifer Temel; Raymond T Chung; Areej El-Jawahri Journal: Liver Transpl Date: 2019-05-03 Impact factor: 5.799
Authors: Ariel Shalev; Veerawat Phongtankuel; Elissa Kozlov; Megan Johnson Shen; Ronald D Adelman; M C Reid Journal: Am J Hosp Palliat Care Date: 2017-06-20 Impact factor: 2.500
Authors: Nwamaka D Eneanya; Julia B Wenger; Katherine Waite; Stanley Crittenden; Derya B Hazar; Angelo Volandes; Jennifer S Temel; Ravi Thadhani; Michael K Paasche-Orlow Journal: Am J Nephrol Date: 2016-06-29 Impact factor: 3.754
Authors: Catherine R Butler; Margaret L Schwarze; Ronit Katz; Susan M Hailpern; William Kreuter; Yoshio N Hall; Maria E Montez Rath; Ann M O'Hare Journal: J Am Soc Nephrol Date: 2019-02-19 Impact factor: 10.121
Authors: Nneka N Ufere; John Donlan; Lauren Waldman; Jules L Dienstag; Lawrence S Friedman; Kathleen E Corey; Nikroo Hashemi; Peter Carolan; Alan C Mullen; Michael Thiim; Irun Bhan; Ryan Nipp; Joseph A Greer; Jennifer S Temel; Raymond T Chung; Areej El-Jawahri Journal: Clin Gastroenterol Hepatol Date: 2019-03-15 Impact factor: 11.382
Authors: Sarah L Goff; Nwamaka D Eneanya; Rebecca Feinberg; Michael J Germain; Lisa Marr; Joan Berzoff; Lewis M Cohen; Mark Unruh Journal: Clin J Am Soc Nephrol Date: 2015-02-13 Impact factor: 8.237
Authors: Vanessa Grubbs; Alvin H Moss; Lewis M Cohen; Michael J Fischer; Michael J Germain; S Vanita Jassal; Jeffrey Perl; Daniel E Weiner; Rajnish Mehrotra Journal: Clin J Am Soc Nephrol Date: 2014-08-07 Impact factor: 8.237